Non-steroidal Anti-inflammatory Drug Gastropathy: Causes and Treatment

References

• Hawkey C J. Non-steroidal anti-inflammatory drugs and ulcers: facts and figures multiply, but do they add up?. Br Med J 1990; 300: 278–84
   PubMed Web of Science ®Google Scholar
• Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827–30
   PubMed Web of Science ®Google Scholar
• Hudson N, Balsitis M, Everitt S, Hawkey C J. Enhanced gastric mucosal leukotriene B4 synthesis in patients on long standing non-steroidal anti-inflammatory drugs. Gut 1993; 34: 742–7
   PubMed Web of Science ®Google Scholar
• Hawkey C J, Hawthorne A B, Hudson N, Cole A T, Mahida Y R, Daneshmend T K. Separation of aspirin's impairment of haemostasis from mucosal injury in the human stomach. Clin Sci 1991; 81: 565–73
   PubMed Web of Science ®Google Scholar
• Cole A T, Brundell S, Hudson N, Hawthorne A B, Mahida Y R, Hawkey C J. Ranitidine, aspirin, food and the stomach. Br Med J 1992; 304: 544–5
   PubMedGoogle Scholar
• Ehsannulah R SB, Page M C, Tildesley G, Wood J R. Prevention of gastroduodenal damage induced by non-steroidal antiinflammatory drugs: controlled trial of ranitidine. Br Med J 1988; 297: 1017–21
   PubMedGoogle Scholar
• Daneshmend T K, Prichard P H, Bhaskar N K, Millns P, Hawkey C J. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine. Gastroenterology 1989; 97: 944–9
   PubMed Web of Science ®Google Scholar
• Hudson N, Taha A S, Russell R I, Sturrock R G, Trye P, Cottrell J, et al. High dose famotidine for healing and subsequent maintenance in non-steroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology 1995; 108(4)A117
   PubMed Web of Science ®Google Scholar
• Daneshmend T K, Stein A G, Bhaskar N H, Hawkey C J. Abolition by omeprazole of aspirin-induced gastric mucosal injury in humans. Gut 1990; 31: 514–7
   PubMed Web of Science ®Google Scholar
• Walan A, Bader J P, Classen M, Lamers C B, Piper D W, Rutgersson K, Eriksson S. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69–75
   PubMed Web of Science ®Google Scholar
• Silverstein F E, Geis G S, Struthers B J, MUCOSA Study Group. NSAIDs and gastrointestinal injury: clinical outcome, the mucosa trial. Gastroenterology 1994; 106(4)A180
   Web of Science ®Google Scholar
• Gabriel S E, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115: 787–96
   PubMed Web of Science ®Google Scholar
• Griffin M R, Piper J M, Daugherty J R, Snowden M, Ray W A. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly patients. Ann Intern Med 1991; 114: 257–63
   PubMed Web of Science ®Google Scholar
• Garca Rodriques L A, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 769–73
   PubMed Web of Science ®Google Scholar
• Langman M JS, Weil J, Wainwright P, Lawson D H, Rawlins M D, Logan R FA, et al. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075–8
   PubMed Web of Science ®Google Scholar
• Cullen D JE, Hawkey G M, Humphries H, Cave R, Shepherd V, Logan R FA, Hawkey C J. Role of non-steroidal anti-inflammatory drugs and Helicobacter pylori in bleeding peptic ulcer. Gastroenterology 1994; 106: A66
   Google Scholar
• Hudson N, Faulkner G, Smith S J, Langman M JS, Hawkey C J, Logan R FA. Late mortality in elderly patients surviving acute peptic ulcer bleeding. Gut 1995; 37: 177–81
   PubMed Web of Science ®Google Scholar
• Elliott S N, McKnight W, Cirino G, Wallace J L. A nitric oxide releasing non-steroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995; 109: 524–30
   PubMed Web of Science ®Google Scholar
• Hawkey C J. Future treatments for arthritis—new NSAIDs, NONSAIDs or no NSAIDs?. Gastroenterology 1995; 109(2)614–6
   PubMed Web of Science ®Google Scholar
• Whittle B J, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99: 607–11
   PubMed Web of Science ®Google Scholar
• Marnett L J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992; 52: 5575–89
   PubMed Web of Science ®Google Scholar
• Marcus A J. Aspirin as prophylalxis against colorectal cancer. N Engl J Med 1995; 333: 656–8
   PubMed Web of Science ®Google Scholar
• Hayllar J, Bjarnasson I. NSAIDs, COX2 inhibitors and the gut. Lancet 1995; 346: 521–2
   PubMed Web of Science ®Google Scholar
• Hawkey C J, Hudson N. Mucosal injury caused by drugs, chemicals and stress. Bockus Gastroenterology 5th ed., W S Haubrich, F Schaffner, J E Berk. WB Saunders. 1994; 2: 656–99
   Google Scholar
• Lancaster-Smith M J, Jaderberg M E, Jackson D A. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991; 32: 252–5
   PubMed Web of Science ®Google Scholar
• Levi S, Goodlad R A, Lee C Y, Stamp G, Walport M J, Wright N A, Hodgson H J. Inhibitory effect of non-steroidal antiinflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336: 840–3
   PubMed Web of Science ®Google Scholar
• Hudson N, Balsitis M, Everitt S, Hawkey C J. Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal antiinflammatory drugs. Gut 1995; 37: 191–4
   PubMed Web of Science ®Google Scholar
• Hull M A, Cullen D JR, Hawkey C J. Basic flbroblast growth factor in gastric ulceration: mucosai levels and therapeutic potential. Gastroenterology 1994; 106: A66
   Web of Science ®Google Scholar
• Kawaguchi H, Pilbeam C C, Gronowicz G, Abreu C, Fletcher B S, Herschman H R, et al. Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest 1995; 96: 932–40
   Web of Science ®Google Scholar
• Hawkey C J, Cullen D JE, Pearson G, Holmes S, Doherty M, Wilson J V, et al. Pharmacoepidemiology of non-steroidal antiinflammatory drug use in Nottingham General Practices: Could ibuprofen be used more widely?. Br Med J, (submitted).
   Google Scholar
• Dieppe P A, Frankel S J, Toth B. Is research into the treatment of osteoarthritis with non-steroidal inflammatory drugs misdirected?. Lancet 1993; 341: 353–4
   PubMed Web of Science ®Google Scholar
• March L, Irwig L, Schwarz J, Simpson J, Chock C, Brooks P. n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. Br Med J 1994; 309: 1041–5
   PubMed Web of Science ®Google Scholar
• Hawkey C J. n of 1 trials in osteoarthritis. Br Med J 1995; 310: 666–7, (letter);
   PubMedGoogle Scholar
• Smalley W E, Griffin M R, Fought R L, Sullivan L, Ray W A. Effect of a prior authorization requirement on the use of nonsteroidal anti-inflammatory drugs by medicaid patients. N Engl J Med 1995; 332: 1612–7
   PubMed Web of Science ®Google Scholar